vs

Side-by-side financial comparison of NATIONAL PRESTO INDUSTRIES INC (NPK) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

NATIONAL PRESTO INDUSTRIES INC is the larger business by last-quarter revenue ($164.0M vs $142.0M, roughly 1.2× Oncology Institute, Inc.). On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 21.7%). NATIONAL PRESTO INDUSTRIES INC produced more free cash flow last quarter ($12.4M vs $2.2M). Over the past eight quarters, NATIONAL PRESTO INDUSTRIES INC's revenue compounded faster (46.3% CAGR vs 22.5%).

National Presto Industries is a company founded in 1905 in Eau Claire, Wisconsin. Originally called "Northwestern Steel and Iron Works" the company changed its name to the "National Pressure Cooker Company" in 1929 and then National Presto Industries, Inc. 1953. The company originally produced pressure canners for commercial, and later home, use. Beginning in 1939, the company introduced small home-use cooking appliances. The company was admitted to the New York Stock Exchange on March 3, 1969.

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

NPK vs TOI — Head-to-Head

Bigger by revenue
NPK
NPK
1.2× larger
NPK
$164.0M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+19.8% gap
TOI
41.6%
21.7%
NPK
More free cash flow
NPK
NPK
$10.3M more FCF
NPK
$12.4M
$2.2M
TOI
Faster 2-yr revenue CAGR
NPK
NPK
Annualised
NPK
46.3%
22.5%
TOI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NPK
NPK
TOI
TOI
Revenue
$164.0M
$142.0M
Net Profit
$-7.5M
Gross Margin
16.9%
Operating Margin
11.4%
-4.9%
Net Margin
-5.3%
Revenue YoY
21.7%
41.6%
Net Profit YoY
43.0%
EPS (diluted)
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NPK
NPK
TOI
TOI
Q4 25
$164.0M
$142.0M
Q3 25
$115.5M
$136.6M
Q2 25
$120.4M
$119.8M
Q1 25
$103.6M
$104.4M
Q4 24
$134.7M
$100.3M
Q3 24
$91.8M
$99.9M
Q2 24
$85.1M
$98.6M
Q1 24
$76.7M
$94.7M
Net Profit
NPK
NPK
TOI
TOI
Q4 25
$-7.5M
Q3 25
$5.3M
$-16.5M
Q2 25
$5.2M
$-17.0M
Q1 25
$7.6M
$-19.6M
Q4 24
$-13.2M
Q3 24
$8.1M
$-16.1M
Q2 24
$6.1M
$-15.5M
Q1 24
$6.6M
$-19.9M
Gross Margin
NPK
NPK
TOI
TOI
Q4 25
16.9%
Q3 25
13.9%
Q2 25
15.4%
Q1 25
17.5%
Q4 24
24.3%
Q3 24
18.8%
Q2 24
17.3%
Q1 24
18.1%
Operating Margin
NPK
NPK
TOI
TOI
Q4 25
11.4%
-4.9%
Q3 25
5.6%
-5.9%
Q2 25
5.1%
-9.4%
Q1 25
8.8%
-9.5%
Q4 24
17.3%
-11.9%
Q3 24
10.0%
-13.9%
Q2 24
7.5%
-16.6%
Q1 24
8.2%
-19.0%
Net Margin
NPK
NPK
TOI
TOI
Q4 25
-5.3%
Q3 25
4.6%
-12.1%
Q2 25
4.3%
-14.2%
Q1 25
7.3%
-18.8%
Q4 24
-13.1%
Q3 24
8.8%
-16.1%
Q2 24
7.1%
-15.7%
Q1 24
8.6%
-21.0%
EPS (diluted)
NPK
NPK
TOI
TOI
Q4 25
$-0.04
Q3 25
$-0.14
Q2 25
$-0.15
Q1 25
$-0.21
Q4 24
$-0.14
Q3 24
$-0.18
Q2 24
$-0.17
Q1 24
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NPK
NPK
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$3.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$395.1M
$-15.7M
Total Assets
$500.7M
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NPK
NPK
TOI
TOI
Q4 25
$3.8M
Q3 25
$4.6M
Q2 25
$4.8M
Q1 25
$5.5M
Q4 24
$22.7M
Q3 24
$33.2M
Q2 24
$53.4M
$9.9M
Q1 24
$87.9M
$29.8M
Stockholders' Equity
NPK
NPK
TOI
TOI
Q4 25
$395.1M
$-15.7M
Q3 25
$379.8M
$-12.3M
Q2 25
$374.1M
$-9.0M
Q1 25
$368.6M
$5.1M
Q4 24
$367.6M
$3.6M
Q3 24
$346.6M
$15.5M
Q2 24
$338.1M
$29.2M
Q1 24
$331.6M
$41.3M
Total Assets
NPK
NPK
TOI
TOI
Q4 25
$500.7M
$164.7M
Q3 25
$503.8M
$163.6M
Q2 25
$471.9M
$159.8M
Q1 25
$455.3M
$164.0M
Q4 24
$453.4M
$172.7M
Q3 24
$428.9M
$179.2M
Q2 24
$418.1M
$179.6M
Q1 24
$417.5M
$204.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NPK
NPK
TOI
TOI
Operating Cash FlowLast quarter
$13.9M
$3.2M
Free Cash FlowOCF − Capex
$12.4M
$2.2M
FCF MarginFCF / Revenue
7.6%
1.5%
Capex IntensityCapex / Revenue
0.9%
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-36.2M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NPK
NPK
TOI
TOI
Q4 25
$13.9M
$3.2M
Q3 25
$-24.6M
$-12.6M
Q2 25
$-10.9M
$-10.2M
Q1 25
$12.5M
$-5.0M
Q4 24
$-7.6M
$4.2M
Q3 24
$-17.5M
$819.0K
Q2 24
$-33.9M
$-15.7M
Q1 24
$5.6M
$-15.9M
Free Cash Flow
NPK
NPK
TOI
TOI
Q4 25
$12.4M
$2.2M
Q3 25
$-24.7M
$-13.2M
Q2 25
$-13.4M
$-11.4M
Q1 25
$-10.5M
$-5.3M
Q4 24
$-11.3M
$2.4M
Q3 24
$-20.3M
$417.0K
Q2 24
$-34.5M
$-17.5M
Q1 24
$5.2M
$-16.5M
FCF Margin
NPK
NPK
TOI
TOI
Q4 25
7.6%
1.5%
Q3 25
-21.4%
-9.7%
Q2 25
-11.1%
-9.5%
Q1 25
-10.2%
-5.1%
Q4 24
-8.4%
2.4%
Q3 24
-22.1%
0.4%
Q2 24
-40.6%
-17.7%
Q1 24
6.7%
-17.4%
Capex Intensity
NPK
NPK
TOI
TOI
Q4 25
0.9%
0.7%
Q3 25
0.1%
0.4%
Q2 25
2.0%
1.0%
Q1 25
22.2%
0.3%
Q4 24
2.7%
1.8%
Q3 24
3.1%
0.4%
Q2 24
0.8%
1.9%
Q1 24
0.5%
0.6%
Cash Conversion
NPK
NPK
TOI
TOI
Q4 25
Q3 25
-4.63×
Q2 25
-2.12×
Q1 25
1.64×
Q4 24
Q3 24
-2.16×
Q2 24
-5.58×
Q1 24
0.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NPK
NPK

Segment breakdown not available.

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons